Proton-pump inhibitors among adults: a nationwide drug-utilization study.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsHálfdánarson, Óskar Ö
Björnsson, Einar S
Lund, Sigrún H
Ogmundsdottir, Margret H
Ogmundsdottir, Helga M
MetadataShow full item record
CitationProton-pump inhibitors among adults: a nationwide drug-utilization study. 2018, 11: doi: 10.1177/1756284818777943 Therapeutic advances in gastroenterology
AbstractThe use of proton-pump inhibitors (PPIs) has grown worldwide, and there are concerns about increased unsubstantiated long-term use. The aim of the study was to describe the real-world use of PPIs over the past decade in an entire national population. This was a nationwide population-based drug-utilization study. Patterns of outpatient PPI use among adults in Iceland between 2003 and 2015 were investigated, including annual incidence and prevalence, duration of use, and dose of tablet used (lower We observed 1,372,790 prescription fills over the entire study period, of which 95% were for higher-dose PPIs. Annual incidence remained stable across time (3.3-4.1 per 100 persons per year), while the annual prevalence increased from 8.5 per 100 persons to 15.5 per 100 persons. Prevalence increased with patient age and was higher among women than men. Duration of treatment increased with patients' age (36% of users over 80 years remained on treatment after 1 year compared with 13% of users aged 19-39 years), and was longer among those initiating on a higher dose compared with a lower dose. The proportion of PPI users concurrently using nonsteroidal anti-inflammatory drugs decreased over the study period, while the proportion concurrently using acetylsalicylic acid, oral anticoagulants, or platelet inhibitors increased. In this nationwide study, a considerable increase in overall outpatient use of PPIs over a 13-year period was observed, particularly among older adults. Patients were increasingly treated for longer durations than recommended by clinical guidelines and mainly with higher doses.
DescriptionTo access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Files
- Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
- Authors: Lassalle M, Le Tri T, Bardou M, Biour M, Kirchgesner J, Rouby F, Dumarcet N, Zureik M, Dray-Spira R
- Issue date: 2020 Mar
- Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study.
- Authors: Pottegård A, Broe A, Hallas J, de Muckadell OB, Lassen AT, Lødrup AB
- Issue date: 2016 Sep
- Proton-pump inhibitor utilization associated with the change to nonpreferred formulary status for esomeprazole in the TRICARE formulary.
- Authors: Linton A, Bacon T, Peterson M
- Issue date: 2009 Jan-Feb
- Use of proton pump inhibitors among Danish children: A 16-year register-based nationwide study.
- Authors: Aznar-Lou I, Reilev M, Lødrup AB, Rubio-Valera M, Haastrup PF, Pottegård A
- Issue date: 2019 Jun
- Use of Proton Pump Inhibitors in Hungary: Mixed-Method Study to Reveal Scale and Characteristics.
- Authors: Matuz M, Benkő R, Engi Z, Schváb K, Doró P, Viola R, Szabó M, Soós G
- Issue date: 2020